Related Experiment Video
Updated: Feb 1, 2026

LabVIEW-operated Novel Nanoliter Osmometer for Ice Binding Protein Investigations
Published on: February 4, 2013
Protein-Losing Enteropathy and Plastic Bronchitis After the Fontan Operation
1Christine Peyton is a clinical nurse specialist at the Heart Institute at Children's Hospital Colorado, Aurora, Colorado. christine.peyton@childrencolorado.org.
Insights
Protein-losing enteropathy and plastic bronchitis are difficult to treat complications after the Fontan procedure. This review covers their causes, and medical and surgical interventions for these challenging conditions in single-ventricle patients.
Area of Science:
- Cardiology
- Pediatric Cardiology
- Critical Care Medicine
Background:
- Protein-losing enteropathy (PLE) and plastic bronchitis (PB) are serious complications following the Fontan procedure.
- These conditions are associated with single-ventricle physiology and Fontan circulation, leading to increased morbidity and mortality.
- Despite advances, treatment remains challenging.
Purpose of the Study:
- To review the pathophysiology of PLE and PB in the context of Fontan physiology.
- To discuss current medical and surgical management strategies for these conditions.
- To highlight risk factors and potential interventions for patients with single-ventricle physiology.
Main Methods:
- Literature review of studies on PLE and PB in Fontan patients.
- Analysis of hemodynamic alterations contributing to these complications.
- Synthesis of information on diagnostic criteria and treatment outcomes.
Main Results:
- Fontan physiology leads to chronically low cardiac output, elevated central venous pressure, and congestive heart failure, contributing to PLE.
- Altered hemodynamics increase mesenteric vascular resistance, causing venous hypertension and gut congestion in PLE.
- High lymphatic pressures in Fontan circulation can lead to acellular bronchial cast formation in PB.
Conclusions:
- PLE and PB are significant challenges in Fontan survivors, linked to altered hemodynamics.
- Understanding the pathophysiology is crucial for effective management.
- A multidisciplinary approach involving medical and surgical interventions is necessary for optimal patient outcomes.
Abstract:
Protein-losing enteropathy and plastic bronchitis remain challenging to treat despite recent treatment advances. Protein-losing enteropathy and plastic bronchitis have been diagnosed in patients with cardiomyopathy, constrictive pericarditis, and congestive heart failure. This article focuses on patients with protein-losing enteropathy or plastic bronchitis following the Fontan procedure. Patients with single-ventricle physiology who have undergone the Fontan procedure are at risk for these conditions. Fontan physiology predisposes patients to chronically low cardiac output, increased central venous pressure, and congestive heart failure. These altered hemodynamics lead to increased mesenteric vascular resistance, resulting in venous hypertension and congestion in protein-losing enteropathy. Plastic bronchitis is a complex disease in which chronic high lymphatic pressures from Fontan physiology cause acellular bronchial casts to develop. These entities may also occur in patients with normal Fontan hemodynamics. This article also covers medical and surgical interventions for protein-losing enteropathy and plastic bronchitis. (Critical Care Nurse 2018;38[6]:e5-e12).
Related Concept Videos
Plasticity
Plasticizers
Plasticizers function by using surface-active agents to create repulsive electrostatic forces between cement particles. This dispersion enhances the concrete's...
Plastic Behavior
Plastic Deformations
Plastic Deformations
Operational Amplifiers

